Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2009

Open Access 01-12-2009 | Case report

Retroperitoneal abscess complicated with necrotizing fasciitis of the thigh in a patient with sigmoid colon cancer

Authors: Yuji Takakura, Satoshi Ikeda, Masanori Yoshimitsu, Takao Hinoi, Daisuke Sumitani, Haruka Takeda, Yasuo Kawaguchi, Manabu Shimomura, Masakazu Tokunaga, Masazumi Okajima, Hideki Ohdan

Published in: World Journal of Surgical Oncology | Issue 1/2009

Login to get access

Abstract

Background

Necrotizing fasciitis of the thigh due to the colon cancer, especially during chemotherepy, has not been previously reported.

Case presentation

A 67-year-old man admitted to the hospital was diagnosed with sigmoid colon cancer that had spread to the left psoas muscle. Multiple hepatic metastases were also found, and combination chemotherapy with irinotecan and S-1 was administered. Four months after the initiation of chemotherapy, the patient developed gait disturbance and high fever and was therefore admitted to the emergency department of our hospital. Blood examination revealed generalized inflammation with a high C-reactive protein level. Computed tomography of the abdomen and pelvis showed gas and fluid collection in the retroperitoneum adjacent to the sigmoid colon cancer. The abscess was locally drained under computed tomographic guidance; however, the infection continued to spread and necrotizing fasciitis developed. Consequently, emergent debridement was performed. The patient recovered well, and the primary tumor was resected after remission of the local inflammation.

Conclusion

Necrotizing fasciitis of the thigh due to the spread of sigmoid colon cancer is unusual, but this fatal complication should be considered during chemotherapy for patients with unresectable colorectal cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levine EG, Manders SM: Life-threatening necrotizing fasciitis. Clin Dermatol. 2005, 23 (2): 144-147. 10.1016/j.clindermatol.2004.06.014.CrossRefPubMed Levine EG, Manders SM: Life-threatening necrotizing fasciitis. Clin Dermatol. 2005, 23 (2): 144-147. 10.1016/j.clindermatol.2004.06.014.CrossRefPubMed
2.
go back to reference Cunningham JD, Silver L, Rudikoff D: Necrotizing fasciitis: a plea for early diagnosis and treatment. Mt Sinai J Med. 2001, 68 (4-5): 253-261.PubMed Cunningham JD, Silver L, Rudikoff D: Necrotizing fasciitis: a plea for early diagnosis and treatment. Mt Sinai J Med. 2001, 68 (4-5): 253-261.PubMed
3.
go back to reference Groth D, Henderson SO: Necrotizing fasciitis due to appendicitis. Am J Emerg Med. 1999, 17 (6): 594-596. 10.1016/S0735-6757(99)90205-X.CrossRefPubMed Groth D, Henderson SO: Necrotizing fasciitis due to appendicitis. Am J Emerg Med. 1999, 17 (6): 594-596. 10.1016/S0735-6757(99)90205-X.CrossRefPubMed
4.
go back to reference Eke N: Fournier's gangrene: a review of 1726 cases. Br J Surg. 2000, 87 (6): 718-728. 10.1046/j.1365-2168.2000.01497.x.CrossRefPubMed Eke N: Fournier's gangrene: a review of 1726 cases. Br J Surg. 2000, 87 (6): 718-728. 10.1046/j.1365-2168.2000.01497.x.CrossRefPubMed
5.
go back to reference Ku HW, Chang KJ, Chen TY, Hsu CW, Chen SC: Abdominal necrotizing fasciitis due to perforated colon cancer. J Emerg Med. 2006, 30 (1): 95-96. 10.1016/j.jemermed.2005.03.014.CrossRefPubMed Ku HW, Chang KJ, Chen TY, Hsu CW, Chen SC: Abdominal necrotizing fasciitis due to perforated colon cancer. J Emerg Med. 2006, 30 (1): 95-96. 10.1016/j.jemermed.2005.03.014.CrossRefPubMed
6.
go back to reference Marron CD, McArdle GT, Rao M, Sinclair S, Moorehead J: Perforated carcinoma of the caecum presenting as necrotising fasciitis of the abdominal wall, the key to early diagnosis and management. BMC Surg. 2006, 6: 11-10.1186/1471-2482-6-11.PubMedCentralCrossRefPubMed Marron CD, McArdle GT, Rao M, Sinclair S, Moorehead J: Perforated carcinoma of the caecum presenting as necrotising fasciitis of the abdominal wall, the key to early diagnosis and management. BMC Surg. 2006, 6: 11-10.1186/1471-2482-6-11.PubMedCentralCrossRefPubMed
7.
go back to reference Lam TP, Maffulli N, Chen EH, Cheng JC: Carcinomatous perforation of the sigmoid colon presenting as a thigh mass. Bull Hosp Jt Dis. 1996, 55 (2): 83-85.PubMed Lam TP, Maffulli N, Chen EH, Cheng JC: Carcinomatous perforation of the sigmoid colon presenting as a thigh mass. Bull Hosp Jt Dis. 1996, 55 (2): 83-85.PubMed
8.
go back to reference Highton L, Clover J, Critchley P: Necrotising fasciitis of the thigh secondary to a perforated rectal cancer. J Plast Reconstr Aesthet Surg. 2008, 62 (2): e17-9. 10.1016/j.bjps.2007.08.031.CrossRefPubMed Highton L, Clover J, Critchley P: Necrotising fasciitis of the thigh secondary to a perforated rectal cancer. J Plast Reconstr Aesthet Surg. 2008, 62 (2): e17-9. 10.1016/j.bjps.2007.08.031.CrossRefPubMed
9.
go back to reference Liu SY, Ng SS, Lee JF: Multi-limb necrotizing fasciitis in a patient with rectal cancer. World J Gastroenterol. 2006, 12 (32): 5256-5258.PubMedCentralPubMed Liu SY, Ng SS, Lee JF: Multi-limb necrotizing fasciitis in a patient with rectal cancer. World J Gastroenterol. 2006, 12 (32): 5256-5258.PubMedCentralPubMed
10.
go back to reference Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet. 2000, 355 (9209): 1041-1047. 10.1016/S0140-6736(00)02034-1.CrossRefPubMed Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet. 2000, 355 (9209): 1041-1047. 10.1016/S0140-6736(00)02034-1.CrossRefPubMed
11.
go back to reference Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004, 22 (1): 23-30. 10.1200/JCO.2004.09.046.CrossRefPubMed Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004, 22 (1): 23-30. 10.1200/JCO.2004.09.046.CrossRefPubMed
12.
go back to reference Grothey A, Sargent D, Goldberg RM, Schmoll HJ: Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol. 2004, 22 (7): 1209-1214. 10.1200/JCO.2004.11.037.CrossRefPubMed Grothey A, Sargent D, Goldberg RM, Schmoll HJ: Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol. 2004, 22 (7): 1209-1214. 10.1200/JCO.2004.11.037.CrossRefPubMed
13.
go back to reference Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004, 350 (23): 2335-2342. 10.1056/NEJMoa032691.CrossRefPubMed Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004, 350 (23): 2335-2342. 10.1056/NEJMoa032691.CrossRefPubMed
14.
go back to reference Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ: Cetuximab for the treatment of colorectal cancer. N Engl J Med. 2007, 357 (20): 2040-2048. 10.1056/NEJMoa071834.CrossRefPubMed Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ: Cetuximab for the treatment of colorectal cancer. N Engl J Med. 2007, 357 (20): 2040-2048. 10.1056/NEJMoa071834.CrossRefPubMed
15.
go back to reference Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S: Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol. 2005, 23 (16): 3706-3712. 10.1200/JCO.2005.00.232.CrossRefPubMed Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S: Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol. 2005, 23 (16): 3706-3712. 10.1200/JCO.2005.00.232.CrossRefPubMed
16.
go back to reference Law WL, Chan WF, Lee YM, Chu KW: Non-curative surgery for colorectal cancer: critical appraisal of outcomes. Int J Colorectal Dis. 2004, 19 (3): 197-202. 10.1007/s00384-003-0551-7.CrossRefPubMed Law WL, Chan WF, Lee YM, Chu KW: Non-curative surgery for colorectal cancer: critical appraisal of outcomes. Int J Colorectal Dis. 2004, 19 (3): 197-202. 10.1007/s00384-003-0551-7.CrossRefPubMed
17.
go back to reference Liu SK, Church JM, Lavery IC, Fazio VW: Operation in patients with incurable colon cancer--is it worthwhile?. Dis Colon Rectum. 1997, 40 (1): 11-14. 10.1007/BF02055675.CrossRefPubMed Liu SK, Church JM, Lavery IC, Fazio VW: Operation in patients with incurable colon cancer--is it worthwhile?. Dis Colon Rectum. 1997, 40 (1): 11-14. 10.1007/BF02055675.CrossRefPubMed
18.
go back to reference Katoh H, Yamashita K, Kokuba Y, Satoh T, Ozawa H, Hatate K, Ihara A, Nakamura T, Onosato W, Watanabe M: Surgical resection of stage IV colorectal cancer and prognosis. World J Surg. 2008, 32 (6): 1130-1137. 10.1007/s00268-008-9535-7.CrossRefPubMed Katoh H, Yamashita K, Kokuba Y, Satoh T, Ozawa H, Hatate K, Ihara A, Nakamura T, Onosato W, Watanabe M: Surgical resection of stage IV colorectal cancer and prognosis. World J Surg. 2008, 32 (6): 1130-1137. 10.1007/s00268-008-9535-7.CrossRefPubMed
19.
go back to reference Beham A, Rentsch M, Pullmann K, Mantouvalou L, Spatz H, Schlitt HJ, Obed A: Survival benefit in patients after palliative resection vs non-resection colon cancer surgery. World J Gastroenterol. 2006, 12 (41): 6634-6638.PubMedCentralPubMed Beham A, Rentsch M, Pullmann K, Mantouvalou L, Spatz H, Schlitt HJ, Obed A: Survival benefit in patients after palliative resection vs non-resection colon cancer surgery. World J Gastroenterol. 2006, 12 (41): 6634-6638.PubMedCentralPubMed
20.
go back to reference Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD: Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg. 2003, 196 (5): 722-728. 10.1016/S1072-7515(03)00136-4.CrossRefPubMed Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD: Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg. 2003, 196 (5): 722-728. 10.1016/S1072-7515(03)00136-4.CrossRefPubMed
21.
go back to reference Saif MW, Elfiky A, Salem RR: Gastrointestinal perforation due to bevacizumab in colorectal cancer. Ann Surg Oncol. 2007, 14 (6): 1860-1869. 10.1245/s10434-006-9337-9.CrossRefPubMed Saif MW, Elfiky A, Salem RR: Gastrointestinal perforation due to bevacizumab in colorectal cancer. Ann Surg Oncol. 2007, 14 (6): 1860-1869. 10.1245/s10434-006-9337-9.CrossRefPubMed
Metadata
Title
Retroperitoneal abscess complicated with necrotizing fasciitis of the thigh in a patient with sigmoid colon cancer
Authors
Yuji Takakura
Satoshi Ikeda
Masanori Yoshimitsu
Takao Hinoi
Daisuke Sumitani
Haruka Takeda
Yasuo Kawaguchi
Manabu Shimomura
Masakazu Tokunaga
Masazumi Okajima
Hideki Ohdan
Publication date
01-12-2009
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2009
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-7-74

Other articles of this Issue 1/2009

World Journal of Surgical Oncology 1/2009 Go to the issue